TI
This company develops clinical diagnostic reagents and medical equipment systems for genomic medicine. Their technology enables saliva-based cancer risk testing by identifying cancer cell-derived glycans, allowing healthcare professionals to detect early-stage cancer risk throughout the body.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This company develops clinical diagnostic reagents and medical equipment systems for genomic medicine. Their technology enables saliva-based cancer risk testing by identifying cancer cell-derived glycans, allowing healthcare professionals to detect early-stage cancer risk throughout the body.